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Purpose: To investigate the role of β1-adrenergic receptors on insulin like growth factor (IGF)-1 receptor signaling and
apoptosis in the retina using β1-adrenergic receptor knockout (KO) mice.
Methods: Western blotting and enzyme-linked immunosorbent assay analyses were done on whole  retinal   lysates from
β1-adrenergic receptor KO mice and wild-type littermates. In addition, vascular analyses of degenerate capillaries and
pericyte ghosts were done on the retina of the β1-adrenergic receptor KO mice versus littermates.
Results: Lack of β1-adrenergic receptors produced a significant increase in both degenerate capillaries and pericyte ghosts.
This  was  accompanied  by  an  increase  in  cleaved  caspase  3  and  tumor  necrosis  factor  α  levels.  IGF-1  receptor
phosphorylation was not changed; however, protein kinase B (Akt) phosphorylation was significantly decreased. The
decrease in Akt phosphorylation is likely caused by increased insulin receptor substrate-1 serine 307 (IRS-1Ser307)
phosphorylation, which is inhibitory to IGF-1 receptor signaling.
Conclusions: These studies further support the idea that maintenance of β-adrenergic receptor signaling is beneficial for
retinal homeostasis. Loss of β1-adrenergic receptor signaling alters tumor necrosis factor α and apoptosis levels in the
retina, as well as Akt and IGF-1 receptor phosphorylation. Since many of these same changes are observed in the diabetic
retina, these data support that novel β-adrenergic receptor agents may provide additional avenues for therapeutics.
Diabetic retinopathy is the leading cause of blindness in
working-age  adults;  however,  other  than  optimal  glucose
control, few therapies exist for the early stages of the disease.
Over the past several years, numerous hypotheses have been
put forward as to the causes of       the  retinal   damage  common
to diabetic retinopathy, including oxidative stress, advanced
glycation end-products, inflammatory factors, altered protein
kinase C signaling, etc. [1-4]. In addition to these hypotheses,
we have reported that loss of sympathetic neurotransmission
produces changes in the retina similar to diabetic retinopathy
[5-7]. We have reported that loss of dopamine β-hydroxylase
(Dbh−/−) produces retinal damage similar to retinopathy [6].
We found that insulin-like growth factor (IGF)-1 receptor
signaling was reduced in the Dbh−/− mice, leading to increased
apoptosis  [8].  These  data  suggested  that  loss  of
norepinephrine signaling could alter IGF-1 receptor signaling
and apoptosis in the retina. It is likely that these changes occur
in retinal endothelial cells, since endothelial cells from other
targets are 100× more responsive to IGF-1 than to insulin
receptor–mediated  signaling  [9].  Additionally,  we  have
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recently shown that retinal endothelial cells respond to a β1-
adrenergic  receptor  agonist  to  regulate  IGF-1  receptor
signaling with minimal changes in the insulin receptor [10].
Additionally, we have found that human retinal endothelial
cells only possess β1 and β3-adrenergic receptors, without
expressing the β2-adrenergic receptor [11]. We have focused
on the β-adrenergic receptors, since we have shown that β-
adrenergic receptor antagonists produce deleterious changes
in the retina [7], while restoration of β-adrenergic signaling to
diabetic rats can prevent the neuronal and vascular changes
associated  with  diabetic  retinopathy  [12].  While  the
mechanism  of  action  for  isoproterenol  has  not  been
established,  it  was  noted  that  diabetes  increased  tumor
necrosis factor (TNF)α levels, which were reduced with the
β-adrenergic  receptor  agonists.  Additionally,  isoproterenol
reduced cleaved caspase 3 levels [10]. Since we have shown
that loss of norepinephrine binding to β-adrenergic receptors
in  the  retina  led  to  decreased  IGF-1  receptor  levels,  we
investigated whether IGF-1 receptor signaling cascades are
altered in mice without β1-adrenergic receptors. Therefore,
we  hypothesized  that  IGF-1  receptor  signaling  would  be
reduced in the retina of β1-adrenergic receptor knockout mice,
leading  to  increased  apoptosis.  While  we  did  observe  an
increase  in  apoptosis,  it  was  mediated  through  TNFα
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1822pathways, rather than IGF-1 receptor signaling, in the β1-
adrenergic receptor knockout mice.
METHODS
Animal preparation: Four- to six-month-old wild-type (WT)
and β1-adrenergic receptor knockout (KO) mice on a hybrid
129/Sv x C57BL/6 background [13] were generated by mating
heterozygotes; genotype was determined by PCR. Retinas
from each animal were obtained from Dr. Steven Thomas
(University of Pennsylvania). The retina was extracted for
protein  analyses  or  whole  globes  removed  for  vascular
analyses. The eyes from these mice appeared grossly normal
and protein amounts from the KO retina were similar to that
collected from WT mice. Only one time point was used for all
analyses.  All  animal  procedures  were  approved  by  the
Institute Animal Care and Use Committees of the University
of Tennessee Health Science Center and the University of
Pennsylvania and followed NIH guidelines.
Western blot analysis: Western blot analysis was done as
described  previously  [10,12].  Primary  antibodies  to  total
IGF-1  receptor  (1:500;  Cell  Signaling,  Danvers,  MA),
phosphorylated IGF-1 receptor (Tyr 1135/1136, 1:500; Cell
Signaling),  phosphorylated  Akt  (Ser473,  1:500;  Cell
Signaling), total Akt (1:500; Cell Signaling), phosphorylated
insulin  receptor  substrate  (IRS)-1(Ser307,  1:500;  Cell
Signaling), total IRS-1 (1:500; Cell Signaling), and IGFBP-3
(1:500;  Gro-Pep,  Novozymes,  Australia)  were  applied
overnight  at  4  °C.  Secondary  antibodies  conjugated  to
horseradish  peroxidase  were  used  at  1:5000  (Promega,
Madison, WI). Western blot membranes were processed using
a Kodak image station 4000 MM system (Carestream Health,
Rochester, NY). Using Prism software (GraphPad software,
San Diego, CA), mean densitometry numbers or the ratio of
mean densitometry of phosphorylated protein to total protein
were used to compare data from β1-adrenergic knockout (KO)
and  control  (WT)  mice  using  Mann–Whitney  tests,  with
p<0.05 being accepted as significant. Data are expressed as
mean densitometry in arbitrary units (A.U.) and in the case of
phosphorylated  protein,  data  are  expressed  as  a  ratio  of
phosphorylated  protein  levels  to  total  protein  levels  in
arbitrary units.
Enzyme-linked  immunosorbent  assay  analyses:  Enzyme-
linked immunosorbent assay (ELISA) analyses for cleaved
caspase 3 (Cell Signaling) and TNFα (Pierce, Rockford, IL)
were performed according to the manufacturer’s instructions.
The ELISA analyses were done in pre-coated 96-well plate
format. Standards were added to the first row, while samples
loaded  in  triplicate  were  added  to  the  remaining  wells.
Following  overnight  incubation,  plates  were  washed  and
secondary antibody was added. After the specified time, plates
were washed and the colorimetric reagent was added to the
plate. Plates were read on a spectrophotometer. An equal
amount of protein was loaded for each sample, so results are
reported as the optical density of the mean± standard error of
the mean (SEM) for the β1-adrenergic receptor KO and WT
mice.
Measurement of degenerate capillaries and pericyte ghosts:
For the acellular capillary and pericyte ghost counts, retinas
from  five  mice  each  of  the  β1-adrenergic  receptor−/−  and
control animals were used. Eyes were enucleated and placed
into  10%  buffered  formalin  for  5  days.  The  retina  was
dissected in 3% crude trypsin solution (Difco Bacto Trypsin
250; Difco, Detroit, MI) containing 0.2 M sodium fluoride at
37 °C for 2 h [14]. The neural retina was gently brushed away
and the remaining retinal vascular tree was dried onto a glass
slide.
Once the isolated retinal vascular tree was dried onto the
glass slide, the slide was stained with hematoxylin-periodic
acid-Schiff. Degenerate (acellular) capillaries were counted
in the midretina in six to seven fields evenly spaced around
the retina. Degenerate capillaries were identified as capillary-
sized  tubes  with  no  nuclei  anywhere  along  their  length.
Degenerate  capillaries  were  counted  only  if  their  average
diameter was at least 20% of that found in surrounding healthy
capillaries.  Pericyte  ghosts  were  estimated  from  the
prevalence of spaces in the capillary basement membranes
from  which  pericytes  had  disappeared.  The  number  of
pericyte ghosts was determined in multiple midretinal fields,
and  is  reported  per  1,000  capillary  cells  [15,16].  All
measurements were done in a masked manner.
RESULTS
Increased degenerate capillaries and pericyte ghosts in β1-
adrenergic  receptor  knockout  mice:  We  have  previously
published  that  dopamine-β-hydroxylase  KO  mice  have
increased  numbers  of  degenerate  capillaries  and  pericyte
ghosts [6], while treatment with topical isoproterenol, a β-
adrenergic receptor agonist, can reduce degenerate capillary
formation in the rat retina [12]. We focused on the vascular
changes in this study as retinal endothelial cells possess β1-
adrenergic receptors and likely undergo apoptosis. We wanted
to  determine  whether  the  loss  of  β1-adrenergic  receptor
signaling was involved in the cell death noted by the formation
of  degenerate  capillaries  and  pericyte  ghosts.  Indeed,  we
found a threefold increase in degenerate capillary formation
and a twofold increase in pericyte ghost formation in the β1-
adrenergic receptor KO mice when compared to their WT
littermates (p<0.05 versus WT, Figure 1).
Cleaved  caspase  3  levels  are  increased  in  whole  retinal
lysates from β1-adrenergic receptor knockout mice: Since we
saw the increased numbers of pericyte ghosts and degenerate
capillaries  in  the  β1-adrenergic  receptor  KO  mice,  we
measured  levels  of  cleaved  caspase  3,  as  a  marker  of
apoptosis. We found a significant increase in the cleavage of
caspase  3  in  the  β1-adrenergic  receptor  KO  animals,  as
compared to WT mice (p<0.05 versus WT, Figure 2).
Molecular Vision 2011; 17:1822-1828 <http://www.molvis.org/molvis/v17/a199> © 2011 Molecular Vision
1823No changes in insulin like growth factor-1 receptor (IGF-1R)
receptor levels between the β1-adrenergic receptor knockout
and  wild-type  mice:  We  recently  published  that  IGF-1R
phosphorylation is significantly decreased in Dbh−/− mice. We
therefore expected that IGF-1R phosphorylation would also
be  decreased  in  mice  lacking  β1-adrenergic  receptors.
Additionally, we have recently shown that the β-adrenergic
receptor  antagonist  propranolol  produced  a  significant
decrease  in  insulin-like  growth  factor  binding  protein
(IGFBP)-3 levels [7], which would decrease the amount of
IGF-1 bound to IGFBP-3 in the circulation, thus allowing
more IGF-1 to bind its receptor. Despite the reduced IGFBP-3
levels in the retina of β1-adrenergic receptor KO mice (p<0.05
versus WT, Figure 3), we found that IGF-1R phosphorylation
is not altered in retinal lysates from β1-adrenergic receptor
knockout mice compared to their littermates (Figure 4).
Figure  2.  Cleaved  caspase  3  is  increased  in  knockout  animals.
Enzyme-linked immunosorbent assay (ELISA) analyses of whole
retinal lysates from β1-adrenergic receptor knockout (KO) animals
versus  their  wild-type  (WT)  littermates.  Caspase  3  levels  are
increased in the knockout mice KO animals. *Significance was found
at p<0.05 versus wildtype samples. Animal numbers (N) is equal to
6.
Despite  no  changes  in  IGF-1R  phosphorylation,  Akt
phosphorylation is reduced: The typical cellular signaling
cascade for the IGF-1R leads to increased phosphorylation of
Akt,  producing  reduced  apoptosis,  which  we  have  shown
previously in retinal endothelial cells [10], in the retina of rats
treated systemically with propranolol [7], and in dopamine β-
hydroxylase KO mice [8]. Since we did not see changes in
IGF-1R phosphorylation, the cascade would predict that Akt
should  not  be  changed,  despite  the  loss  of  β1-adrenergic
receptors. However, the phosphorylation of Akt is reduced in
the  β1-adrenergic  receptor  KO  mice  (p<0.05  versus  WT,
Figure 5). These data for Akt could explain the increase in
cleaved  caspase  3  levels,  since  Akt  typically  inhibits  the
cleavage  of  caspase  3.  However,  it  is  unclear  why  Akt
phosphorylation is reduced in mice with no changes in IGF-1R
phosphorylation.
Figure 3. Retina from β1-adrenergic receptor has reduced insulin-
like growth factor binding protein (IGFBP)-3 levels. Representative
blots and bar graph of IGFBP-3 protein levels in whole retinal lysates
in the β1-adrenergic receptor knockout (KO) mice and their wild-
type  (WT)  controls.  *Significance  was  found  at  p<0.05  versus
wildtype samples. Animal numbers (N) is equal to 6.
Figure  1.  Degenerate  capillaries  and
pericyte  ghosts  in  the  β1-adrenergic
receptor retina A: This panel is a bar
graph  of  the  number  of  degenerate
capillaries in the β1-adrenergic receptor
knockout (KO) mice versus wild-type
(WT) littermates. B: This panel is a bar
graph of the number of pericyte ghosts
in the same samples of retina from β1-
adrenergic receptor KO and their WT
littermates. *p<0.05 versus WT. n=5 for
each group.
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knockout  mice:  In  addition  to  the  increased  cleavage  of
caspase 3, a significant increase in TNFα levels were observed
in the β1-adrenergic receptor KO mice (p<0.05 versus WT,
Figure  6).  This  follows  our  previous  findings  of  reduced
TNFα levels in diabetic animals treated with β-adrenergic
receptor agonists [12], and in retinal Müller cells cultured in
high glucose [17].
Increased  IRS-1Ser307  in  β1-adrenergic  receptor  knockout
mice, potentially due to increased TNFα levels: Work on
adipocytes  has  suggested  that  increased  TNFα  levels  can
produce increased phosphorylation of IRS-1 on serine 307,
which is inhibitory to insulin/IGF-1 receptor signaling [18,
19]. We have found a similar phenomenon in retinal Müller
cells cultured in high glucose (Walker et al., in submission).
An increase in IRS-1Ser307 would limit the signaling of IGF-1R
to Akt, resulting in increased cleaved caspase 3 levels. Indeed,
we observed that IRS-1Ser307 phosphorylation is significantly
increased (46%) in the retina of the β1-adrenergic receptor KO
mice as compared to their WT littermates (p<0.05, Figure 7).
Taken  together,  the  increased  TNFα  levels  in  the  β1-
adrenergic  receptor  knockout  mice  likely  decreases  Akt
activity, producing increased apoptosis in the retina of the
β1-adrenergic receptor KO mice.
DISCUSSION
We hypothesized that IGF-1 signaling would be decreased in
the β1-adrenergic receptor KO mouse retina, as we observed
Figure  4.  Insulin  like  growth  factor-1  (IGF-1)  receptor
phosphorylation does not change in β1-adrenergic receptor knockout
retina. Representative blots and bar graph of phosphorylated IGF-1
receptor (Tyr 1135/1136) and total IGF-1 receptor protein levels in
retinal lysates in the β1-adrenergic receptor knockout (KO) mice and
the wild-type (WT) controls. Bar graph is the ratio of phosphorylated
protein to total protein levels. *Significance was found at p<0.05
versus wildtype samples. Animal numbers (N) is equal to 6.
in the Dbh−/− mouse retina. The loss of IGF-1R signaling
would increase apoptosis, which could explain the increased
numbers  of  degenerate  capillaries  and  pericyte  ghosts.
However,  we  did  not  observe  changes  in  IGF-1R
phosphorylation in the retinal lysates from the β1-adrenergic
receptor KO mice. Yet, we did find a significant increase in
the  cleavage  of  caspase  3,  as  well  as  reduced  Akt
phosphorylation.  Taken  together,  this  suggested  that
something was different in the cellular signaling of the retina
from β1-adrenergic receptor KO mice, compared to retinal
samples from Dbh−/− mice.
Figure 5. Despite no change in insulin like growth factor-1 receptor
phosphorylation, Akt phosphorylation is reduced in retina from β1-
adrenergic receptor knockout mice. Representative blots and bar
graph of the ratio of phosphorylated Akt (Ser 473) to total Akt protein
levels in retinal lysates in the β1-adrenergic receptor knockout (KO)
mice and the wild-type (WT) controls. *p<0.05 versus WT. n=5.
Figure 6. Enzyme linked immunosorbent assay results demonstrate
that lack of β1-adrenergic receptors increases tumor necrosis factor
a  levels.  Significance  demonstrates  that  p<0.05  versus  wildtype
samples. Seven animals in each group were used for these studies.
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endothelial  cells  and  retinal  Müller  cells  respond  very
different to altered β-adrenergic receptor signaling; however,
both cell types respond to β-adrenergic receptor stimulation
with a reduction in TNFα levels and cleaved caspase 3 [17,
20,21]. Based on these findings, we would expect that retinal
lysates from β1-adrenergic receptor KO mice would have
increased TNFα levels and cleaved caspase 3 levels, which
was observed in this study. The question at hand was why are
caspase 3 levels increased when IGF-1R phosphorylation is
not altered? Furthermore, does TNFα have a direct link to
apoptosis in the retina of β1-adrenergic receptor KO mice?
Over the past 15 years or more, the regulation of IGF-1
signaling  has  become  of  increasing  importance,  as  many
reported that IGF-1 signaling may regulate longevity [22].
IGFBPs comprise a large family of highly regulated proteins
originally found to regulate the bioavailability of IGF-I to bind
its tyrosine kinase receptor [22]. IGFBPs regulate the delivery
of IGF molecules to local tissues [23], with the predominating
IGFBP species determined by cell type and local conditions.
Important to this study is that IGFBP-3 may play a novel role
to prevent endothelial cell apoptosis in an IGF-independent
manner [24,25]. The protective effects of IGFBP-3 in primary
retinal  endothelial  cells  appear  to  contrast  with  reported
actions of IGFBP-3 in immortalized cancer cell lines, where
it has been well established that IGFBP-3 promotes apoptosis
via several IGF-independent mechanisms [26-28]. We have
previously reported that propranolol, a β-adrenergic receptor
antagonist, leads to a decrease in IGFBP-3 protein levels [7].
Figure  7.  Insulin  receptor  substrate-1  serine  307  (IRS-1Ser307)  is
increased in retinal lysates from β1-adrenergic receptor knockout
mice.  Western  blot  image  and  bar  graph  of  the  ratio  of
phosphorylated  IRS-1Ser307  to  total  IRS-1  in  the  retina  of  β1-
adrenergic receptor knockout (KO) mice versus wild-type (WT)
littermates. *p<0.05 versus WT, n=4.
In the present study, we find significantly reduced IGFBP-3
protein levels in the β1-adrenergic receptor KO mouse retina,
which follows the findings from the work with propranolol.
Since others have reported that IGFBP-3 can be antiapoptotic
to the retina in the oxygen-induced retinopathy model [25,
29], these findings suggest that the increased cleaved caspase
3 observed in the β1-adrenergic receptor KO mice may be due
to reduced levels of IGFBP-3 in the retinal endothelial cells,
resulting  in  increased  apoptosis  through  IGF-1  receptor-
independent effects.
In addition to the antiapoptotic actions of IGFBP-3, the
increase  in  TNFα  levels  may  also  be  responsible  for  the
increased  cleaved  caspase  3  levels  in  the  β1-adrenergic
receptor knockout mice. TNFα may regulate apoptosis in one
of two ways: through inhibition of insulin/IGF-1 signaling
[30,31]  or  directly  through  the  death  receptor  pathway.
Ultimately, both pathways lead to increased cleaved caspase
3 levels. Based on the increased IRS-1Ser307 levels in the β1-
adrenergic receptor knockout retinal lysates, it appears more
likely that the increased TNFα in the KO animals inhibits any
antiapoptotic  actions  of  IGF-1R.  This  finding  has  been
reported in other cell types, specifically in adipocytes and
muscle [18,19]. The increase in IRS-1Ser307 could explain why
Akt  phosphorylation  was  reduced,  despite  no  change  in
IGF-1R  phosphorylation.  Therefore,  data  suggest  that
increased TNFα levels inhibit IGF-1R signaling to Akt, which
results  in  increased  cleaved  caspase  3  levels,  as  well  as
increased degenerate capillaries and pericyte ghosts.
While the data suggest that the increased cleaved caspase
3 levels can be induced in two separate ways based on data
presented in this study (through decreased IGFBP-3 levels and
increased IRS-1Ser307 phosphorylation), alterations in insulin
signaling could also be involved. In the present study, we did
not investigate insulin receptor since we have recently shown
that β1-adrenergic receptors have limited actions on insulin
receptor phosphorylation [10]. Based on the work by Panjala,
insulin receptor phosphorylation would be increased in the
β1-adrenergic  receptor  KO  mice,  which  would  inhibit
apoptosis. This does not follow the findings in the current
study.  Additionally,  work  in  other  endothelial  cells  has
suggested that endothelial cells have a 100× preference for
IGF-1 receptor signaling over insulin receptor signaling [9].
An additional limitation of the present study is that we did not
look  at  changes  in  the  retinal  morphology,  other  than
degenerate capillaries. While the eyes from the KO and WT
animals were grossly normal and no differences in overall
retinal vasculature were noted, measurements of the retina
were not obtained. However, when analyses of protein content
are  considered,  no  significant  differences  in  total  retinal
proteins were noted between the β1-adrenergic receptor KO
mice and the WT mice. Finally, analyses of multiple time
points would be optimal. Unfortunately, in the present study,
we only collected retinal samples from one time point in these
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both neural and vascular changes in this mouse model.
Overall, this is the first study of the retinal signaling and
vascular  morphology  in  the  β1-adrenergic  receptor  KO
animals. Data support work in the surgical sympathectomy
and  Dbh−/−  mice  to  demonstrate  that  loss  of  sympathetic
neurotransmission can produce retinal damage. In addition to
finding that β1-adrenergic receptor signaling is involved in
maintenance of retinal homeostasis, these findings suggest
that increased TNFα levels and/or reduced IGFBP-3 protein
levels are involved in the proapoptotic response observed in
the  retinas  from  β1-adrenergic  receptor  KO  mice.  Future
studies will focus on the cellular mechanisms by which β-
adrenergic  receptors  can  directly  regulate  IGFBP-3  and
TNFα to prevent retinal damage. Nonetheless, these findings
further  support  the  hypothesis  that  loss  of  sympathetic
neurotransmission is involved in the retinal vascular changes
similar to those occurring in diabetic retinopathy, and suggest
that maintenance of β-adrenergic receptor signaling may offer
a novel therapeutic for retinal disease.
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